<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7013637/results/search/country/results.xml">
  <result pre="of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in" exact="Germany" post="RungeMelanie1KrenselMagdalene2https://orcid.org/0000-0003-3442-8382WestermannClaudia1*BindlDominik3NagelsKlaus3https://orcid.org/0000-0002-4026-8728AugustinMatthias2NienhausAlbert14[1], melanierunge1994@gmail.comalbert.nienhaus@bgw-online.de[2], m.krensel@uke.dem.augustin@uke.de[3], dominik.bindl@uni-bayreuth.deklaus.nagels@uni-bayreuth.de[4], *Correspondence: c.westermann@uke.de epub: 2020-1-1ppub: 2020-1172440received:"/>
  <result pre="HP for whom an occupational CHC infection was recognised in" exact="Germany" post="between 2000 and 2017. The data records contain sociodemographic"/>
  <result pre="cost effectiveness of DAAs in an international comparison, however for" exact="Germany" post="there are as yet only a small number. In"/>
  <result pre="were measured using the SVR12 rate in a CEA from" exact="Germany" post="[43]; Giesel et al. calculated an ICER of €1560.13"/>
  <result pre="comprising both treatment-naive patients and patients with treatment experience from" exact="the USA." post="SOF-based therapies exhibited cost effectiveness with an ICER of"/>
  <result pre="occupational disease reports for HP from non-governmental health institutions in" exact="Germany" post="are taken into account. Health care systems, supply structures,"/>
  <result pre="cirrhosis. A study of 200 patientsJ. Hepatol.20044082383010.1016/j.jhep.2004.01.00515094231 38.ThuluvathP.J.GuidingerM.K.FungJ.J.JohnsonL.B.RayhillS.C.PelletierS.J.Liver transplantation in" exact="the United States," post="1999–2008Am. J. Transpl.2010101003101910.1111/j.1600-6143.2010.03037.x20420649 39.DavisG.L.AlterM.J.El-SeragH.PoynardT.JenningsL.W.Aging of hepatitis C virus (HCV)-infected"/>
  <result pre="A study of 200 patientsJ. Hepatol.20044082383010.1016/j.jhep.2004.01.00515094231 38.ThuluvathP.J.GuidingerM.K.FungJ.J.JohnsonL.B.RayhillS.C.PelletierS.J.Liver transplantation in the" exact="United States," post="1999–2008Am. J. Transpl.2010101003101910.1111/j.1600-6143.2010.03037.x20420649 39.DavisG.L.AlterM.J.El-SeragH.PoynardT.JenningsL.W.Aging of hepatitis C virus (HCV)-infected"/>
  <result pre="analysis modelLiver Transpl.20101674875910.1002/lt.2207220517909 42.WolfeR.A.RoysE.C.MerionR.M.Trends in organ donation and transplantation in" exact="the United States," post="1999–2008Am. J. Transpl.20101096197210.1111/j.1600-6143.2010.03021.x 43.GisselC.GötzG.MahlichJ.ReppH.Cost-effectiveness of Interferon-free therapy for Hepatitis"/>
  <result pre="modelLiver Transpl.20101674875910.1002/lt.2207220517909 42.WolfeR.A.RoysE.C.MerionR.M.Trends in organ donation and transplantation in the" exact="United States," post="1999–2008Am. J. Transpl.20101096197210.1111/j.1600-6143.2010.03021.x 43.GisselC.GötzG.MahlichJ.ReppH.Cost-effectiveness of Interferon-free therapy for Hepatitis"/>
 </snippets>
</snippetsTree>
